← Leaderboards
Elaine M. Smith
University Of Iowa
$5,017,147
Attributed
$5,017,147
Total exposure
7
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $440.8K · FY2005–12$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$5,017,147 · 7
By mechanism
R01$4,177,326 · 3
R03$422,230 · 2
R21$290,723 · 1
T32$126,868 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Iowa
Same institution · by research overlap
- George J Weiner$29,916,936
- Paul A Romitti$26,134,328
- Jeffrey C Murray$40,323,548
- Charles F Lynch$23,710,168
- Peter S Thorne$26,236,012
Others in their field
Top investigators on “Cancer Risk”
- Gregory H Reaman · National Childhood Cancer Foundation$242,495,090
- David Heimbrook · Leidos Biomedical Research, Inc.$222,048,828
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Philip J Disaia · University Of California Irvine$144,085,463
- Mitchell D Schnall · University Of Pennsylvania$138,156,012
- Peter C Adamson · National Childhood Cancer Foundation$128,266,602
Research focus
Cancer RiskPolymerase Chain ReactionHuman PapillomavirusGene ExpressionClinical ResearchHuman SubjectTumor Suppressor GenesGene MutationP53 Gene /ProteinOral Pharyngeal NeoplasmVirus GeneticsBiomarkerNeoplasm /Cancer GeneticsSouthern BlottingNucleic Acid HybridizationCarcinogenesisSite Directed MutagenesisGenetic PolymorphismComorbidityGenetic SusceptibilityBiopsyCytologyPathologic ProcessPrognosis
Grant awards (21)
Risk Factor Differences by HPV Serology and Tumor DNA Among INHANCE Participants$151,000
R03 · FY2012 · DE · contact PI
Risk Factor Differences by HPV Serology and Tumor DNA Among INHANCE Participants$150,750
R03 · FY2011 · DE · contact PI
Transcripitonal and Genetic Profiles in HNSCCs$281,653
R01 · FY2008 · DE · contact PI
Transcripitonal and Genetic Profiles in HNSCCs$284,786
R01 · FY2007 · DE · contact PI
International Collaborative HNC Research$143,223
R21 · FY2007 · DE · contact PI
Transcripitonal and Genetic Profiles in HNSCCs$293,292
R01 · FY2006 · DE · contact PI
International Collaborative HNC Research$147,500
R21 · FY2006 · DE · contact PI
Transcripitonal and Genetic Profiles in HNSCCs$300,350
R01 · FY2005 · DE
Transcripitonal and Genetic Profiles in HNSCCs$312,225
R01 · FY2004 · DE
GENETIC EPIDEMIOLOGY AND MECHANISMS IN ORAL CANCER$775,418
R01 · FY2003 · DE
HPV AND RISK OF ORAL CANCER IN THE CZECH REPUBLIC$40,160
R03 · FY2003 · TW
GENETIC EPIDEMIOLOGY AND MECHANISMS IN ORAL CANCER$394,947
R01 · FY2002 · DE
GENETIC EPIDEMIOLOGY AND MECHANISMS IN ORAL CANCER$361,251
R01 · FY2002 · DE
Seroepidemiologic Study of HPV and Oral Cancer$261,077
R01 · FY2002 · DE
HPV AND RISK OF ORAL CANCER IN THE CZECH REPUBLIC$40,160
R03 · FY2002 · TW
GENETIC EPIDEMIOLOGY AND MECHANISMS IN ORAL CANCER$353,094
R01 · FY2001 · DE
RESEARCH TRAINING IN CLINICAL TRIALS$100,920
T32 · FY2001 · DC
HPV AND RISK OF ORAL CANCER IN THE CZECH REPUBLIC$40,160
R03 · FY2001 · TW
GENETIC EPIDEMIOLOGY AND MECHANISMS IN ORAL CANCER$352,520
R01 · FY2000 · DE
HPV TRANSMISSION AND RISK OF ORAL CANCER$206,713
R01 · FY2000 · DE
RESEARCH TRAINING IN CLINICAL TRIALS$25,948
T32 · FY2000 · DC